Explaining additional genetic variation in complex traits

Trends in Genetics

Volumn 30, Issue 4, 2014, Pages 124-132

  Robinson, Matthew R ^a   Wray, Naomi R ^a   Visscher, Peter M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COPY NUMBER VARIATION; DISEASES; EFFECT SIZE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; GENOTYPE; HUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE GENETICS; QUANTITATIVE TRAIT; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STUDY DESIGN; ANIMAL; GENETICS;

ANIMALS; GENETIC VARIATION; GENOME; HUMANS; PHENOTYPE; QUANTITATIVE TRAIT, HERITABLE;

EID: 84897058188     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2014.02.003     Document Type: Review

References (107)

1. Lango Allen H., et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010, 467:832-838.
2. Lee S.H., et al. Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat. Genet. 2012, 44:247-250.
3. Visscher P.M., et al. Five years of GWAS discovery. Am. J. Hum. Genet. 2012, 90:7-24.
4. Ripke S., et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 2013, 45:1150-1159.
5. Morris A.P., et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 2012, 44:981-990.
6. Schunkert H., et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 2011, 43:333-338.
7. Teslovich T.M., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466. 707-713.
8. Kemper K.E., Goddard M.E. Understanding and predicting complex traits: knowledge from cattle. Hum. Mol. Genet. 2012, 21:R45-R51.
9. Scriver C.R. The PAH gene, phenylketonuria, and a paradigm shift. Hum. Mutat. 2007, 28:831-845.
10. Sosnay P.R., et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat. Genet. 2013, 45:1160-1167.
11. MacDonald M.E., et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
12. Steinberg M.H., Rodgers G.P. Pathophysiology of sickle cell disease: role of cellular and genetic modifiers. Semin. Hematol. 2001, 38:299-306.
13. Lee S.H., et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 2013, 45:984-994.
14. Blair D.R., et al. A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk. Cell 2013, 155:70-80.
15. Sklar P., et al. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat. Genet. 2011, 43:977-983.
16. Connolly J.J., et al. A genome-wide association study of autism incorporating autism diagnostic interview-revised, autism diagnostic observation schedule, and social responsiveness scale. Child Dev. 2013, 84:17-33.
17. Neale B.M., et al. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 2010, 49:884-897.
18. Ripke S., et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol. Psychiatry 2013, 18:497-511.
19. Cordell H.J., et al. Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16. Nat. Genet. 2013, 45:822-824.
20. Lettre G., et al. Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet. 2011, 7:e1001300.
21. Yang J., et al. FTO genotype is associated with phenotypic variability of body mass index. Nature 2012, 490:267-272.
22. Speliotes E.K., et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 2010, 42:937-948.
23. Bloom J.S., et al. Finding the sources of missing heritability in a yeast cross. Nature 2013, 494:234-237.
24. Eyre-Walker A. Evolution in health and medicine Sackler colloquium: Genetic architecture of a complex trait and its implications for fitness and genome-wide association studies. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(Suppl.):1752-1756.
25. Hill W.G., et al. Data and theory point to mainly additive genetic variance for complex traits. PLoS Genet. 2008, 4:e1000008.
26. Stahl E.A., et al. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat. Genet. 2012, 44:483-489.
27. Vattikuti S., et al. Heritability and genetic correlations explained by common SNPs for metabolic syndrome traits. PLoS Genet. 2012, 8:e1002637.
28. Yang J., et al. Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 2010, 42:565-569.
29. Yang J., et al. Ubiquitous polygenicity of human complex traits: genome-wide analysis of 49 traits in Koreans. PLoS Genet. 2013, 9:e1003355.
30. Agarwala V., et al. Evaluating empirical bounds on complex disease genetic architecture. Nat. Genet. 2013, 45:1418-1427.
31. Dickson S.P., et al. Rare variants create synthetic genome-wide associations. PLoS Biol. 2010, 8:e1000294.
32. Mitchell K.J. What is complex about complex disorders?. Genome Biol. 2012, 13:237.
33. Wang K., et al. Interpretation of association signals and identification of causal variants from genome-wide association studies. Am. J. Hum. Genet. 2010, 86:730-742.
34. Wray N.R., et al. Synthetic associations created by rare variants do not explain most GWAS results. PLoS Biol. 2011, 9:e1000579.
35. Anderson C.A., et al. Synthetic associations are unlikely to account for many common disease genome-wide association signals. PLoS Biol. 2011, 9:e1000580.
36. Medina-Gomez C., et al. Meta-analysis of genome-wide scans for total body BMD in children and adults reveals allelic heterogeneity and age-specific effects at the WNT16 locus. PLoS Genet. 2012, 8:e1002718.
37. Park J-H., et al. Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:18026-18031.
38. Flister M.J., et al. Identifying multiple causative genes at a single GWAS locus. Genome Res. 2013, 10.1101/gr.160283.113.
39. Stranger B.E., et al. Progress and promise of genome-wide association studies for human complex trait genetics. Genetics 2011, 187:367-383.
40. Carlson C.S., et al. Generalization and dilution of association results from European GWAS in populations of non-European ancestry: the PAGE study. PLoS Biol. 2013, 11:e1001661.
41. Pritchard J.K., et al. The genetics of human adaptation: hard sweeps, soft sweeps, and polygenic adaptation. Curr. Biol. 2010, 20:R208-R215.
42. Okada Y., et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2013, 10.1038/nature12873.
43. Parkes M., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 2007, 39:830-832.
44. Di Paolo G., Kim T-W. Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat. Rev. Neurosci. 2011, 12:284-296.
45. Manolio T.A., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
46. Abecasis G.R., et al. A map of human genome variation from population-scale sequencing. Nature 2010, 467:1061-1073.
47. Awadalla P., et al. Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am. J. Hum. Genet. 2010, 87:316-324.
48. Roach J.C., et al. Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 2010, 328:636-639.
49. Kong A., et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 2012, 488:471-475.
50. Gazave E., et al. Population growth inflates the per-individual number of deleterious mutations and reduces their mean effect. Genetics 2013, 195:969-978.
51. Cohen J., et al. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat. Genet. 2005, 37:161-165.
52. Cohen J.C., et al. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 2006, 354:1264-1272.
53. Dauber A., et al. Genome-wide association of copy-number variation reveals an association between short stature and the presence of low-frequency genomic deletions. Am. J. Hum. Genet. 2011, 89:751-759.
54. Kirov G., et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 2012, 17:142-153.
55. Malhotra D., et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 2011, 72:951-963.
56. Ashley E.A., et al. Clinical assessment incorporating a personal genome. Lancet 2010, 375:1525-1535.
57. Worthey E.A., et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet. Med. 2011, 13:255-262.
58. Nijbroek G., et al. Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am. J. Hum. Genet. 1995, 57:8-21.
59. Murphy K.C., et al. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch. Gen. Psychiatry 1999, 56:940-945.
60. Williams H.J., et al. Schizophrenia two-hit hypothesis in velo-cardio facial syndrome. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2013, 162B:177-182.
61. Purcell S.M., et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014, 506:185-190.
62. Cruchaga C., et al. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease. Nature 2013, 505:550-554.
63. Bonnefond A., et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat. Genet. 2012, 44:297-301.
64. Ji W., et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat. Genet. 2008, 40:592-599.
65. Mitchell K.J., Porteous D.J. Rethinking the genetic architecture of schizophrenia. Psychol. Med. 2011, 41:19-32.
66. Nelson R.M., et al. A century after Fisher: time for a new paradigm in quantitative genetics. Trends Genet. 2013, 29:669-676.
67. Yang J., et al. Sporadic cases are the norm for complex disease. Eur. J. Hum. Genet. 2010, 18:1039-1043.
68. Visscher P.M., et al. Evidence-based psychiatric genetics, AKA the false dichotomy between common and rare variant hypotheses. Mol. Psychiatry 2012, 17:474-485.
69. Barton N.H., Keightley P.D. Understanding quantitative genetic variation. Nat. Rev. Genet. 2002, 3:11-21.
70. Gratten J., et al. Interpreting the role of de novo protein-coding mutations in neuropsychiatric disease. Nat. Genet. 2013, 45:234-238.
71. Cheng K-F., Chen J-H. Detecting rare variants in case-parents association studies. PLoS ONE 2013, 8:e74310.
72. Hannan A.J. TRPing up the genome: tandem repeat polymorphisms as dynamic sources of genetic variability in health and disease. Discov. Med. 2010, 10:314-321.
73. Kapur S., et al. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?. Mol. Psychiatry 2012, 17:1174-1179.
74. Xu, M. et al. (2013) The New Perspectives on Genetic Studies of Type 2 Diabetes and Thyroid Diseases, Bentham Science Publishers.
75. Fall T., Ingelsson E. Genome-wide association studies of obesity and metabolic syndrome. Mol. Cell. Endocrinol. 2012, 382:740-757.
76. Wang Y., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365:671-679.
77. Slamon D.J., et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182.
78. Ferraldeschi R., Newman W.G. Pharmacogenetics and pharmacogenomics: a clinical reality. Ann. Clin. Biochem. 2011, 48:410-417.
79. Traylor M., et al. Using phenotypic heterogeneity to increase the power of genome-wide association studies: application to age at onset of ischaemic stroke subphenotypes. Genet. Epidemiol. 2013, 37:495-503.
80. Perry J.R.B., et al. Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. PLoS Genet. 2012, 8:e1002741.
81. O'Reilly P.F., et al. MultiPhen: joint model of multiple phenotypes can increase discovery in GWAS. PLoS ONE 2012, 7:e34861.
82. Warde-Farley D., et al. Mixture model for sub-phenotyping in GWAS. Pac. Symp. Biocomput. 2012, 2012:363-374.
83. Hall M-H., Smoller J.W. A new role for endophenotypes in the GWAS era: functional characterization of risk variants. Harv. Rev. Psychiatry 2010, 18:67-74.
84. Greenwood T.A., et al. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am. J. Psychiatry 2013, 170:521-532.
85. Braff D.L., et al. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr. Bull. 2007, 33:21-32.
86. Van Dongen J., Boomsma D.I. The evolutionary paradox and the missing heritability of schizophrenia. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2013, 162B:122-136.
87. Cruchaga C., et al. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron 2013, 78:256-268.
88. Schork A.J., et al. All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs. PLoS Genet. 2013, 9:e1003449.
89. Trynka G., et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 2013, 45:124-130.
90. Edwards S.L., et al. Beyond GWASs: illuminating the dark road from association to function. Am. J. Hum. Genet. 2013, 93:779-797.
91. Knight J., et al. Using functional annotation for the empirical determination of Bayes Factors for genome-wide association study analysis. PLoS ONE 2011, 6:e14808.
92. Henrichsen C.N., et al. Copy number variants, diseases and gene expression. Hum. Mol. Genet. 2009, 18:R1-R8.
93. Pinto D., et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466:368-372.
94. Levinson D.F., et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am. J. Psychiatry 2011, 168:302-316.
95. Joseph B., et al. Cytoplasmic genetic variation and extensive cytonuclear interactions influence natural variation in the metabolome. Elife 2013, 2:e00776.
96. Samuels D.C., et al. Recurrent tissue-specific mtDNA mutations are common in humans. PLoS Genet. 2013, 9:e1003929.
97. Wang L., et al. Gene set analysis of genome-wide association studies: Methodological issues and perspectives. Genomics 2011, 98:1-8.
98. Uemoto Y., et al. The power of regional heritability analysis for rare and common variant detection: simulations and application to eye biometrical traits. Front. Genet. 2013, 4:232.
99. Ehret G.B., et al. A multi-SNP locus-association method reveals a substantial fraction of the missing heritability. Am. J. Hum. Genet. 2012, 91:863-871.
100. Yang J., et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 2012, 44:369-375.
101. Hemani G., et al. An evolutionary perspective on epistasis and the missing heritability. PLoS Genet. 2013, 9:e1003295.
102. Buyske S. Maternal genotype effects can alias case genotype effects in case-control studies. Eur. J. Hum. Genet. 2008, 16:783-785.
103. Thomas D. Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies. Annu. Rev. Public Health 2010, 31:21-36.
104. Liu D.J., Leal S.M. A novel adaptive method for the analysis of next-generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions. PLoS Genet. 2010, 6:e1001156.
105. Lynch M., Walsh B. Genetics and Analysis of Quantitative Traits 1998, Sinauer Associates.
106. Hill W.G., Zhang X-S. On the pleiotropic structure of the genotype-phenotype map and the evolvability of complex organisms. Genetics 2012, 190:1131-1137.
107. Szymczak S., et al. Machine learning in genome-wide association studies. Genet. Epidemiol. 2009, 33(Suppl. 1):S51-S57.